218 related articles for article (PubMed ID: 15100671)
1. Levocetirizine better protects than desloratadine in a nasal provocation with allergen.
Deruaz C; Leimgruber A; Berney M; Pradervand E; Spertini F
J Allergy Clin Immunol; 2004 Apr; 113(4):669-76. PubMed ID: 15100671
[TBL] [Abstract][Full Text] [Related]
2. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.
Ciebiada M; Górska-Ciebiada M; DuBuske LM; Górski P
Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277
[TBL] [Abstract][Full Text] [Related]
3. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
4. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Desloratadine and Levocetirizine in Patients with Cedar Pollen-Induced Allergic Rhinitis: A Randomized, Double-Blind Study.
Yonekura S; Okamoto Y; Sakurai D; Iinuma T; Sakurai T; Yoneda R; Kurita J; Hanazawa T; Kawasaki Y
Int Arch Allergy Immunol; 2019; 180(4):274-283. PubMed ID: 31618733
[TBL] [Abstract][Full Text] [Related]
6. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo.
Popov TA; Dumitrascu D; Bachvarova A; Bocsan C; Dimitrov V; Church MK
Inflamm Res; 2006 Jun; 55(6):241-4. PubMed ID: 16955243
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine.
Frossard N; Strolin-Benedetti M; Purohit A; Pauli G
Br J Clin Pharmacol; 2008 Feb; 65(2):172-9. PubMed ID: 17953719
[TBL] [Abstract][Full Text] [Related]
8. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
Stübner P; Zieglmayer R; Horak F
Curr Med Res Opin; 2004 Jun; 20(6):891-902. PubMed ID: 15200748
[TBL] [Abstract][Full Text] [Related]
9. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Tosca MA
Clin Exp Allergy; 2004 Jun; 34(6):958-64. PubMed ID: 15196286
[TBL] [Abstract][Full Text] [Related]
10. Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients.
Reinartz SM; Overbeek SE; Kleinjan A; van Drunen CM; Braunstahl GJ; Hoogsteden HC; Fokkens WJ
Allergy; 2005 Oct; 60(10):1301-7. PubMed ID: 16134997
[TBL] [Abstract][Full Text] [Related]
11. Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU).
Day JH; Briscoe MP; Rafeiro E; Ratz JD
Int J Clin Pract; 2004 Feb; 58(2):109-18. PubMed ID: 15055856
[TBL] [Abstract][Full Text] [Related]
12. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Kłos K; Kruszewski J; Kruszewski R; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
[TBL] [Abstract][Full Text] [Related]
13. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
Greiff L; Persson CG; Andersson M
Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours.
Passalacqua G; Guerra L; Compalati E; Massacane P; Rogkakou A; Zanella C; Baena-Cagnani R; Canonica GW
Int Arch Allergy Immunol; 2004 Oct; 135(2):143-7. PubMed ID: 15345913
[TBL] [Abstract][Full Text] [Related]
15. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis.
Lee DK; Gardiner M; Haggart K; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):650-3. PubMed ID: 15080821
[TBL] [Abstract][Full Text] [Related]
18. Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H.
Mandhane SN; Shah JH; Bahekar PC; Mehetre SV; Pawar CA; Bagad AS; Chidrewar GU; Rao CT; Rajamannar T
Int Arch Allergy Immunol; 2010; 151(1):56-69. PubMed ID: 19672097
[TBL] [Abstract][Full Text] [Related]
19. Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine.
Persi L; Demoly P; Harris AG; Tisserand B; Michel FB; Bousquet J
J Allergy Clin Immunol; 1999 Apr; 103(4):591-4. PubMed ID: 10200006
[TBL] [Abstract][Full Text] [Related]
20. The new antihistamines--desloratadine and levocetirizine: a review.
Scheinfeld N
J Drugs Dermatol; 2002 Dec; 1(3):311-6. PubMed ID: 12851991
[No Abstract] [Full Text] [Related]
[Next] [New Search]